Insufficient scRNA-seq data for expression of SIRT4 at single-cell level.
Insufficient scRNA-seq data for expression of SIRT4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 98% | 121.80 | 222 / 226 | 100% | 5.96 | 404 / 406 |
| kidney | 99% | 128.78 | 88 / 89 | 99% | 4.49 | 888 / 901 |
| brain | 97% | 115.44 | 2569 / 2642 | 100% | 5.93 | 705 / 705 |
| prostate | 96% | 81.67 | 235 / 245 | 100% | 4.41 | 500 / 502 |
| skin | 96% | 78.83 | 1743 / 1809 | 97% | 3.40 | 459 / 472 |
| thymus | 97% | 94.98 | 636 / 653 | 96% | 4.12 | 582 / 605 |
| uterus | 99% | 112.67 | 169 / 170 | 93% | 3.83 | 425 / 459 |
| pancreas | 94% | 59.62 | 308 / 328 | 96% | 2.97 | 171 / 178 |
| ovary | 96% | 95.47 | 172 / 180 | 93% | 3.05 | 400 / 430 |
| breast | 88% | 58.31 | 405 / 459 | 98% | 3.63 | 1096 / 1118 |
| adrenal gland | 98% | 215.85 | 253 / 258 | 83% | 5.35 | 190 / 230 |
| bladder | 100% | 87.67 | 21 / 21 | 76% | 2.11 | 385 / 504 |
| lung | 81% | 65.35 | 470 / 578 | 91% | 2.86 | 1047 / 1155 |
| stomach | 98% | 102.41 | 351 / 359 | 66% | 1.42 | 190 / 286 |
| intestine | 98% | 121.39 | 948 / 966 | 65% | 1.35 | 340 / 527 |
| esophagus | 93% | 81.71 | 1338 / 1445 | 63% | 1.56 | 116 / 183 |
| spleen | 99% | 94.59 | 239 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 4.01 | 79 / 80 |
| muscle | 98% | 188.93 | 790 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 2.53 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 3.20 | 28 / 29 |
| heart | 95% | 134.43 | 818 / 861 | 0% | 0 | 0 / 0 |
| adipose | 79% | 45.48 | 946 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 71% | 36.47 | 948 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 43% | 16.55 | 395 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006974 | Biological process | DNA damage response |
| GO_0000820 | Biological process | regulation of glutamine family amino acid metabolic process |
| GO_0006541 | Biological process | glutamine metabolic process |
| GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
| GO_0046676 | Biological process | negative regulation of insulin secretion |
| GO_1903217 | Biological process | negative regulation of protein processing involved in protein targeting to mitochondrion |
| GO_0034983 | Biological process | peptidyl-lysine deacetylation |
| GO_0007005 | Biological process | mitochondrion organization |
| GO_0046322 | Biological process | negative regulation of fatty acid oxidation |
| GO_0072350 | Biological process | tricarboxylic acid metabolic process |
| GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
| GO_0040029 | Biological process | epigenetic regulation of gene expression |
| GO_1904182 | Biological process | regulation of pyruvate dehydrogenase activity |
| GO_0071456 | Biological process | cellular response to hypoxia |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0016779 | Molecular function | nucleotidyltransferase activity |
| GO_0061690 | Molecular function | lipoamidase activity |
| GO_0106419 | Molecular function | NAD-dependent protein lipoamidase activity |
| GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
| GO_0106420 | Molecular function | NAD-dependent protein biotinidase activity |
| GO_0140803 | Molecular function | NAD+- protein-cysteine ADP-ribosyltransferase activity |
| GO_0004407 | Molecular function | histone deacetylase activity |
| GO_0070403 | Molecular function | NAD+ binding |
| GO_0034979 | Molecular function | NAD-dependent protein lysine deacetylase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_1990404 | Molecular function | NAD+-protein ADP-ribosyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SIRT4 |
| Protein name | NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4) (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4) Sirtuin 4 |
| Synonyms | SIR2L4 |
| Description | FUNCTION: Acts as a NAD-dependent protein lipoamidase, biotinylase, deacetylase and ADP-ribosyl transferase . Catalyzes more efficiently removal of lipoyl- and biotinyl- than acetyl-lysine modifications . Inhibits the pyruvate dehydrogenase complex (PDH) activity via the enzymatic hydrolysis of the lipoamide cofactor from the E2 component, DLAT, in a phosphorylation-independent manner . Catalyzes the transfer of ADP-ribosyl groups onto target proteins, including mitochondrial GLUD1, inhibiting GLUD1 enzyme activity . Acts as a negative regulator of mitochondrial glutamine metabolism by mediating mono ADP-ribosylation of GLUD1: expressed in response to DNA damage and negatively regulates anaplerosis by inhibiting GLUD1, leading to block metabolism of glutamine into tricarboxylic acid cycle and promoting cell cycle arrest . In response to mTORC1 signal, SIRT4 expression is repressed, promoting anaplerosis and cell proliferation . Acts as a tumor suppressor . Also acts as a NAD-dependent protein deacetylase: mediates deacetylation of 'Lys-471' of MLYCD, inhibiting its activity, thereby acting as a regulator of lipid homeostasis (By similarity). Does not seem to deacetylate PC . Controls fatty acid oxidation by inhibiting PPARA transcriptional activation . Impairs SIRT1-PPARA interaction probably through the regulation of NAD(+) levels . Down-regulates insulin secretion . . |
| Accessions | F5H4X9 ENST00000202967.4 ENST00000536460.1 Q9Y6E7 |